When does the Cabometyx (cabozantinib) patent expire?
Cabometyx (cabozantinib) is protected by multiple patents, and the end of exclusivity depends on which one is being asked about (drug substance, formulation, dosing regimens, or specific indications). That also means “patent expiration” and “market exclusivity” can happen at different times.
For the most up-to-date patent-expiration targets tied to Cabometyx, DrugPatentWatch.com tracks the relevant patent landscape and dates. You can check Cabometyx on DrugPatentWatch here: DrugPatentWatch – Cabometyx (cabozantinib). [1]
Does exclusivity end at the same time as the last patent?
Not necessarily. A product can have patents expiring on one timeline while regulatory exclusivity protections (separate from patents) can keep certain competitive products off the market until later. That’s why users searching for “Cabometyx patent expiration” often need a specific date tied to a specific patent number or exclusivity type.
DrugPatentWatch.com is useful here because it lists and organizes patents that affect generic or biosimilar/alternative entry timing. [1]
Which patents are most relevant for generic entry risk?
Companies and generic filers usually focus on the patents that actually block competition for the exact product claims they want to copy, which may include:
- active ingredient (drug substance) coverage
- specific formulations or delivery methods
- combinations or dosing regimens
- method-of-use patents for particular indications
Because Cabometyx has a multi-patent footprint, the “most relevant” one can change depending on the intended copy (route/formulation) and the indication being pursued. DrugPatentWatch’s brand patent pages help narrow down which patents and dates drive the practical entry timeline. [1]
Where to find the exact Cabometyx expiration date you need
If you want a single date for decision-making (for example, whether a generic could launch), you typically need either:
- the specific patent number and expiration date, or
- the specific regulatory exclusivity bucket being referenced
DrugPatentWatch.com provides a navigable view of Cabometyx’s patent schedule so you can match the date to the patent(s) of interest. [1]
Sources
[1] DrugPatentWatch – Cabometyx (cabozantinib)